Form 4 for IDXX Idexx Laboratories
Accepted 2022-03-07 00:00:00 ET · period of report 2022-03-04 · accession 0001567619-22-006475 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-07 | 2022-03-04 | IDXX | MAZELSKY JONATHAN JAY | Pres, CEO, Dir | G - Gift | $0.00 | -500 | 50.6K | -1.0% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-04 | G | D | 500 | $0.00 | 50,585.64 | D | — | — |